LABT 8-K: Delisting notice

Filed with the SEC on · accession 0001213900-26-120724

LABT filed a 8-K (current report) with the SEC on Nov 16, 2026. Lakewood-Amedex Biotherapeutics received a Nasdaq delisting notice after its stock traded below $1.00 for 30 consecutive business days, and because it had already done a 1-for-10 reverse split within the past year, it is not eligible for a standard compliance period.

Summary of the filing

Lakewood-Amedex Biotherapeutics received a Nasdaq delisting notice after its stock traded below $1.00 for 30 consecutive business days, and because it had already done a 1-for-10 reverse split within the past year, it is not eligible for a standard compliance period. The company intends to request a hearing to stay the suspension and present a plan to regain compliance.

Key details

Minimum bid price required for continued listing$1
RegistrantLakewood-Amedex Biotherapeutics Inc.
Listing exchange issuing delisting noticeThe Nasdaq Stock Market LLC
Chief executive officerKelvin Cooper

✦ Ask GOAX AI about this filing — what it means for LABT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LABT?

Click here

Frequently asked questions

What did LABT file with the SEC on Nov 16, 2026?

LABT filed a 8-K (Delisting notice). Lakewood-Amedex Biotherapeutics received a Nasdaq delisting notice after its stock traded below $1.00 for 30 consecutive business days, and because it had already done a 1-for-10 reverse split within the past year, it is not eligible for a standard compliance period. The company intends to request a hearing to stay the suspension and present a plan to regain compliance.

What does a delisting notice mean for LABT stock?

The stock often falls sharply. In a Chapter 11 reorganization existing shares are frequently cancelled or heavily diluted; in Chapter 7 the company is liquidated and shareholders are paid last, usually nothing.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other LABT SEC filings

Get alerts when LABT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days